John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$275M |
| 2 |
Netflix
NFLX
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$242M |
| 4 |
Qualcomm
QCOM
|
+$236M |
| 5 |
Starbucks
SBUX
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$236M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$221M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$191M |
| 4 |
McDonald's
MCD
|
+$183M |
| 5 |
Union Pacific
UNP
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Healthcare | 12.88% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 10.88% |
| 5 | Industrials | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYRA
2751
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $64.2K | ﹤0.01% |
+328
| New | +$58.7K |
|
2752
Cumberland Pharmaceuticals
CPIX
$117M
| $62.8K | ﹤0.01% |
33,230
| – | – |
|
|
DAO
2753
Youdao
DAO
$2.02B
| $62.5K | ﹤0.01% |
15,538
-12,036
| -44% | -$50.7K |
|
2754
MeiraGTx Holdings
MGTX
$1.42B
| $62.4K | ﹤0.01% |
12,700
-3,400
| -21% | -$20.6K |
|
|
THRX
2755
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $60.9K | ﹤0.01% |
22,651
-29,150
| -56% | -$114K |
|
|
RERE
2756
ATRenew
RERE
$906M
| $60.7K | ﹤0.01% |
26,616
-20,181
| -43% | -$50.7K |
|
2757
Scilex Holding
SCLX
$39.8M
| $59.6K | ﹤0.01% |
1,217
-67
| -5% | -$9.18K |
|
2758
LanzaTech Global Warrant
LNZAW
$3.04M
| $59.6K | ﹤0.01% |
+97,700
| New | +$68K |
|
|
EMAN
2759
DELISTED
eMagin Corporation
EMAN
| $59.3K | ﹤0.01% |
29,800
| – | – |
|
2760
The ONE Group
STKS
$52.1M
| $58.4K | ﹤0.01% |
10,617
-60,136
| -85% | -$408K |
|
2761
HeartCore Enterprises
HTCR
$3.85M
| $57.2K | ﹤0.01% |
2,900
-140
| -5% | -$3.46K |
|
2762
Kaltura
KLTR
$249M
| $57.1K | ﹤0.01% |
+33,024
| New | +$65.2K |
|
|
NAAS
2763
NaaS Technology Inc
NAAS
$55.9M
| $54K | ﹤0.01% |
+48
| New | +$87.8K |
|
2764
Intellicheck
IDN
$58.6M
| $53.9K | ﹤0.01% |
23,962
-2,000
| -8% | -$5.04K |
|
2765
Ocugen
OCGN
$461M
| $53.8K | ﹤0.01% |
134,582
+80,139
| +147% | +$39.6K |
|
2766
Lantronix
LTRX
$256M
| $53.8K | ﹤0.01% |
+12,089
| New | +$53.1K |
|
2767
loanDepot
LDI
$301M
| $53.3K | ﹤0.01% |
31,012
+18,512
| +148% | +$37.7K |
|
|
CDTX
2768
DELISTED
Cidara Therapeutics
CDTX
| $52.9K | ﹤0.01% |
2,805
-8,356
| -75% | -$164K |
|
|
CWBR
2769
DELISTED
CohBar, Inc. Common Stock
CWBR
| $52.3K | ﹤0.01% |
16,856
+3,683
| +28% | +$10.9K |
|
|
CMLS
2770
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $52.1K | ﹤0.01% |
10,244
-18,602
| -64% | -$88.3K |
|
2771
Arbutus Biopharma
ABUS
$1.03B
| $51.4K | ﹤0.01% |
25,312
-35,991
| -59% | -$75.5K |
|
2772
Compass Therapeutics
CMPX
$432M
| $50.6K | ﹤0.01% |
+25,700
| New | +$63.5K |
|
|
RBOT
2773
DELISTED
Vicarious Surgical
RBOT
| $50.3K | ﹤0.01% |
+2,836
| New | +$103K |
|
2774
GrowGeneration
GRWG
$102M
| $49.8K | ﹤0.01% |
+17,068
| New | +$56K |
|
|
ALLG.WS
2775
DELISTED
Allego N.V. Warrants
ALLG.WS
| $49.5K | ﹤0.01% |
133,500
| – | – |
|
Similar funds
John Overdeck's Q3 2023 Portfolio in Review
As of Q3 2023, John Overdeck held 3,402 positions worth $37.2B, down 6.8% from $39.9B the previous quarter. Its ten largest holdings account for 7% of the portfolio.
John Overdeck withdrew a net $1.95B in Q3 2023, closing 472 positions and reducing 1,183 holdings. Its most notable exit was Etsy, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Eli Lilly worth $232M.
- John Overdeck's largest Q3 2023 buy was Eli Lilly: 432,734 shares worth $232M.
- John Overdeck added most to Advanced Micro Devices in Q3 2023, an estimated $275M increase.
- John Overdeck's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $236M.
- John Overdeck fully exited Etsy in Q3 2023, selling an estimated $144M.
- John Overdeck's ten largest holdings make up 7% of its $37.2B portfolio in Q3 2023.
- John Overdeck opened 430 new positions and closed 472 in Q3 2023.
- John Overdeck's portfolio value fell 6.8% quarter-over-quarter to $37.2B.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.